罗欣药业 (002793)
Luoxin Pharmaceuticals Group Stock Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 108758.85
- Circulating A-Shares(W): 108593.53
- Earnings Per Share(RMB): 0.0216
- Net Assets Per Share(RMB): 1.3355
- Operating Revenue(W RMB): 172341.52
- Total Profit(W RMB): 5131.89
- Net Profit Attributable to Parent(W RMB): 2292.68
- Net Profit Growth Rate(%): 108.64
- Weighted Return on Equity(%): 1.62
- Operating Cash Flow Per Share(RMB): 0.2580
- Undistributed Profit Per Share(RMB): -0.0619
- Capital Reserve Per Share(RMB): 0.3674
2. Main Business
The main business covers:
- Research, production and sales of pharmaceutical products
3. Company Basic Information
- Company Name: Luoxin Pharmaceuticals Group Stock Co., Ltd.
- Listing Date: 2016-04-15
- Industry: Pharmaceutical Manufacturing
- Address: 4th Building, No.18 Luoqi Road, Luozhuang District, Linyi City, Shandong Province; 7th Floor, Building A, Phase I, Qian Tan Shi Mao Center, No. 255 Dongyu Road, Pudong New District, Shanghai
- Website: www.luoxin.cn
- Company Profile: The company was established through the overall change of Dongyin Co., Ltd. On May 28, 2012, approved by the first shareholders' meeting, the original shareholders of Dongyin Co., Ltd. acted as promoters, converting the audited net assets of 151,869,296.72 yuan as of December 31, 2011 into 75 million shares, with a par value of 1 yuan per share. The excess of net assets over share capital, 76,869,296.72 yuan, was recorded as capital reserve. Dongyin Co., Ltd. was wholly transformed into a joint stock company. Tianjian Certified Public Accountants verified the receipt of the registered capital at the time of the overall change and issued the "Tianjian Yan (2012) No. 153" "Capital Verification Report". On June 7, 2012, Dongyin Pump Industry completed the industrial and commercial registration procedures at the Taizhou Administration for Industry and Commerce and obtained the "331081100011767" "Business License of Enterprise Legal Person" with a registered capital of 75 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shandong Luoxin Holding Co., Ltd. | General Legal Person | 23695.55 | 21.82 |
| 2 | Shanghai Zhongjue Private Fund Management Co., Ltd. - Zhongjue Zhongju Zengli No.1 Private Securities Investment Fund | Private Securities Investment Fund | 5437.94 | 5.01 |
| 3 | ALLY BRIDGE FLAGSHIP LX(HK)LIMITED | General Legal Person | 4660.95 | 4.29 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 3033.83 | 2.79 |
| 5 | Karamay Deyi Xinhua Equity Investment Limited Partnership | General Legal Person | 2496.14 | 2.30 |
| 6 | Deyi Investment Management (Beijing) Co., Ltd. - Chengdu Deyi Xinhua Equity Investment Partnership (Limited Partnership) | General Legal Person | 2310.27 | 2.13 |
| 7 | Luoxin Pharmaceuticals Group Stock Co., Ltd. - 2024 Employee Stock Ownership Plan | Asset Management Plan | 1821.95 | 1.68 |
5. Concept Sectors
- Private Hospital
- Smart Healthcare
- Generic Drugs
- Helicobacter Pylori
- Innovative Drugs
- Private Placement Plan
- Consecutive Losses
- Equity Transfer
- New Private Placement Entry
- Heavy Private Placement Holdings
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information